drugset / Trial / NCT04869800
Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
RandomizedCrossoverOpen-labelTreatment
Summary
A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-398
Timeline
- Start
- 2021-05-27
- Primary completion
- 2021-06-07
- Completion
- 2021-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 25 mg | — |
| Subject | Lobeglitazone | Small molecule | 0.5 mg | — |